代谢物：肿瘤学的新视角。
Oncometabolites: A new insight for oncology.
机构信息
Urology Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Chronic Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
出版信息
Mol Genet Genomic Med. 2019 Sep;7(9):e873. doi: 10.1002/mgg3.873. Epub 2019 Jul 18.
Abstract
The new aspect of oncometabolite can be an indicator of genetic and epigenetic change and cancer biomarker.
摘要
新的代谢物可以作为遗传和表观遗传变化以及癌症生物标志物的指标。
相似文献
1
Oncometabolites: A new insight for oncology.
Mol Genet Genomic Med. 2019 Sep;7(9):e873. doi: 10.1002/mgg3.873. Epub 2019 Jul 18.
2
A systems approach to predict oncometabolites via context-specific genome-scale metabolic networks.
PLoS Comput Biol. 2014 Sep 18;10(9):e1003837. doi: 10.1371/journal.pcbi.1003837. eCollection 2014 Sep.
3
Oncometabolites: A New Paradigm for Oncology, Metabolism, and the Clinical Laboratory.
Clin Chem. 2017 Dec;63(12):1812-1820. doi: 10.1373/clinchem.2016.267666. Epub 2017 Oct 16.
4
Detection, mechanisms, and therapeutic implications of oncometabolites.
Trends Endocrinol Metab. 2023 Dec;34(12):849-861. doi: 10.1016/j.tem.2023.08.018. Epub 2023 Sep 20.
5
Oncometabolites: linking altered metabolism with cancer.
J Clin Invest. 2013 Sep;123(9):3652-8. doi: 10.1172/JCI67228. Epub 2013 Sep 3.
6
28th meeting of the Italian Cancer Society (SIC). New challenges of molecular oncology.
Tumori. 2002 Jan-Feb;88(1):77-81.
7
Oncometabolites-driven tumorigenesis: From genetics to targeted therapy.
Int J Cancer. 2014 Nov 15;135(10):2237-48. doi: 10.1002/ijc.29080. Epub 2014 Aug 14.
8
9
Emerging trends in biomarker discovery: Ease of prognosis and prediction in cancer.
Semin Cancer Biol. 2018 Oct;52(Pt 1):iii-iv. doi: 10.1016/j.semcancer.2018.05.008. Epub 2018 May 29.
10
Oncometabolites in Cancer: Current Understanding and Challenges.
Cancer Res. 2021 Jun 1;81(11):2820-2823. doi: 10.1158/0008-5472.CAN-20-3730. Epub 2021 Mar 24.
引用本文的文献
1
The emerging role of dysregulated propionate metabolism and methylmalonic acid in metabolic disease, aging, and cancer.
Cell Metab. 2025 Feb 4;37(2):316-329. doi: 10.1016/j.cmet.2025.01.005.
2
Transcending frontiers in prostate cancer: the role of oncometabolites on epigenetic regulation, CSCs, and tumor microenvironment to identify new therapeutic strategies.
Cell Commun Signal. 2024 Jan 12;22(1):36. doi: 10.1186/s12964-023-01462-0.
3
Targeting Oncometabolites in Peritoneal Cancers: Preclinical Insights and Therapeutic Strategies.
Metabolites. 2023 Apr 30;13(5):618. doi: 10.3390/metabo13050618.
4
Regulative Roles of Metabolic Plasticity Caused by Mitochondrial Oxidative Phosphorylation and Glycolysis on the Initiation and Progression of Tumorigenesis.
Int J Mol Sci. 2023 Apr 11;24(8):7076. doi: 10.3390/ijms24087076.
5
Enhancing clinical potential of liquid biopsy through a multi-omic approach: A systematic review.
Front Genet. 2023 Apr 3;14:1152470. doi: 10.3389/fgene.2023.1152470. eCollection 2023.
6
Imaging 2-hydroxyglutarate and other brain oncometabolites pertinent to critical genomic alterations in brain tumors.
BJR Open. 2023 Mar 22;5(1):20210070. doi: 10.1259/bjro.20210070. eCollection 2023.
7
Potent Inhibition of Macropinocytosis by Niclosamide in Cancer Cells: A Novel Mechanism for the Anticancer Efficacy for the Antihelminthic.
Cancers (Basel). 2023 Jan 26;15(3):759. doi: 10.3390/cancers15030759.
8
Metabolomics of small extracellular vesicles derived from isocitrate dehydrogenase 1-mutant HCT116 cells collected by semi-automated size exclusion chromatography.
Front Mol Biosci. 2023 Jan 11;9:1049402. doi: 10.3389/fmolb.2022.1049402. eCollection 2022.
9
The Impact of Covid-19 Pandemic on Genitourinary Cancers Stage and Grade.
Clin Genitourin Cancer. 2023 Feb;21(1):84-90. doi: 10.1016/j.clgc.2022.11.016. Epub 2022 Nov 24.
10
Epigenetic Reprogramming of the Glucose Metabolic Pathways by the Chromatin Effectors During Cancer.
Subcell Biochem. 2022;100:269-336. doi: 10.1007/978-3-031-07634-3_9.
本文引用的文献
1
Oncometabolites in cancer aggressiveness and tumour repopulation.
Biol Rev Camb Philos Soc. 2019 Aug;94(4):1530-1546. doi: 10.1111/brv.12513. Epub 2019 Apr 10.
2
Liquid Biopsy in Thyroid Cancer: New Insight.
Int J Hematol Oncol Stem Cell Res. 2018 Jul 1;12(3):235-248.
3
The presence of tumor extrachomosomal circular DNA (ecDNA) as a component of liquid biopsy in blood.
Med Hypotheses. 2018 May;114:5-7. doi: 10.1016/j.mehy.2018.02.018. Epub 2018 Feb 26.
4
O-GlcNAc in cancer: An Oncometabolism-fueled vicious cycle.
J Bioenerg Biomembr. 2018 Jun;50(3):155-173. doi: 10.1007/s10863-018-9751-2. Epub 2018 Mar 29.
5
TOF-SIMS analysis of an isocitrate dehydrogenase 1 mutation-associated oncometabolite in cancer cells.
Biointerphases. 2018 Jan 30;13(3):03B404. doi: 10.1116/1.5013633.
6
The Potential of Circulating Tumor Cells in Personalized Management of Breast Cancer: A Systematic Review.
Acta Med Iran. 2017 Mar;55(3):175-193.
7
The α-ketoglutarate dehydrogenase complex in cancer metabolic plasticity.
Cancer Metab. 2017 Feb 2;5:3. doi: 10.1186/s40170-017-0165-0. eCollection 2017.
8
Fundamentals of cancer metabolism.
Sci Adv. 2016 May 27;2(5):e1600200. doi: 10.1126/sciadv.1600200. eCollection 2016 May.
9
Emerging applications of metabolomics in drug discovery and precision medicine.
Nat Rev Drug Discov. 2016 Jul;15(7):473-84. doi: 10.1038/nrd.2016.32. Epub 2016 Mar 11.
10
Oncometabolites: tailoring our genes.
FEBS J. 2015 Aug;282(15):2796-805. doi: 10.1111/febs.13295. Epub 2015 Apr 30.
Zotero 插件